The latest regarding weight-loss drugs: 

• Eli Lilly's experimental medication mimicking 3 hormones  yielded a 24% weight loss on the highest dose over 48 weeks in a phase 2 trial, the most seen yet.

• Wall Street’s obsession with next-generation obesity and diabetes treatments intensified over the weekend as drugmakers presented new clinical-trial data on the drugs